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A B S T R A C T
Anaerobic bacteremia (AB) is usually detected in about 0.5–13% of positive blood cultures. The aim of this
study was to determine prevalence of anaerobic bacteremia over a 5-year period (2013–2017), to identify
current trends at our University Hospital and to compare the results to those in a similar study (2005–2009)
in the same region. During the study period, an average of 23,274 ± 2,756 blood cultures were received per
year. Out of the positive blood cultures, 3.3–3.6% (n = 423) yielded anaerobic bacteria, representing 3.5–3.8
anaerobic isolates/1000 blood culture bottles (including both aerobic and anaerobic bottles) per year for hos-
pitalized patients. Mean age of affected patients was 70–73 years (range: 18–102 years) with a male-to-fe-
male ratio: 0.60. Most isolated anaerobes were Cutibacterium spp. (54.0 ± 8.5%; n= 247), while among anaer-
obes other than Cutibacterium spp., Bacteroides and Parabacteroides and Clostridium spp. were the most
prevalent. Blood culture time-to-positivity (TTP) for clinically relevant bacteria was 31.4 ± 23.4h, while for
Cutibacterium spp., TTP values were 112.9 ± 37.2 h (p < 0.0001). In conclusion, the prevalence of anaerobic
bacteremia should be determined on institutional basis.
© 2020.
1. Introduction
Obligate anaerobic bacteria may be important pathogens at virtu-
ally all anatomical sites and are causative agents in multiorgan fail-
ure, which can be serious and life-threatening [1]. Because anaerobes
are the predominant members of the human microbiome, especially
in the intestinal tract and on various mucous membranes, they are a
common cause of infections of endogenous origin, in addition to ex-
ogenous infections, such as bite wounds and gas gangrene [2]. Anaer-
obic bacteremia is detected in about 0.5–13% of all positive blood
cultures, mainly depending on the type of the healthcare institution
(primary- or tertiary) and/or hospital ward (presence or absence of
immunocompromised patients) submitting the blood culture samples
[3,4]. Due to the variation in clinical and laboratory practices among
the different institutions worldwide, potentially inaccurate epidemio-
logical data may be reported. In spite of its infrequent occurrence, the
mortality rate associated with anaerobic bacteremia still remains very
high (ranging between 25% and 44%) [1,5,6]. The characterization of
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the main risk factors associated with mortality in patients with anaer-
obic bacteremia was performed in the 1970s. Advanced age, polymi-
crobial infection and the presence of severe underlying diseases were
considered as factors contributing to fatal outcome [7]. The adminis-
tration of delayed or inappropriate antibiotic therapy against these mi-
croorganisms or the lack of surgical intervention may also lead to fail-
ures in eradication of these infections [1,7]. The isolation of anaero-
bic bacteria has specific requirements that should be strictly followed
[8]. The management of anaerobic infections is difficult due to the
slow growth of many anaerobes, which can delay the identification,
the frequent polymicrobial nature of the infections and the increas-
ing resistance of anaerobic bacteria [2]. The number of reports of
multidrug-resistant (MDR) anaerobic strains (most often Bacteroides/
Parabacteroides spp.) has increased in the past decade [9]. The signif-
icance of inappropriate antimicrobial treatment on the mortality rate
of patients with anaerobic bacteremia was highlighted by several stud-
ies previously [10,11], although the exact association of these factors
was not always conclusive, because inadequate source control (surgi-
cal therapy or drainage of abscesses) is also an important point to con-
sider.
There is value in attaining blood both in aerobic and anaerobic
blood cultures; clinicians and laboratory personnel at each institution
https://doi.org/10.1016/j.anaerobe.2020.102200
1075-9964/ © 2020.
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should determine the prevalence of anaerobic bacteremia and use this
information to guide the practice of taking blood cultures.
The aim of our study was to conduct a 5-year retrospective study
to evaluate the incidence of anaerobic bacteremia in hospitalized pa-
tients and to establish whether a shift in the frequency or distribution
has occurred, compared to a similar study in the same institution, over
the same 5-year time period (2005–2009) [12].
2. Materials and methods
2.1. Study design, data collection
This retrospective observational study was performed on the ba-
sis of microbiological data collected, corresponding to a 5-year period
(from January 1, 2013 to December 31, 2017). During this time, the
Institute of Clinical Microbiology was the National Reference Labo-
ratory of Anaerobic Bacteria in Hungary. The laboratory is the rou-
tine diagnostic microbiological laboratory of a (currently) 1,820-bed
tertiary-care university-teaching hospital with a broad-profile, affili-
ated with the University of Szeged in Szeged, Hungary. The Clinical
Center is responsible for the medical care of a population of around
600,000 patients in the southeast region of Hungary [13]. The Clini-
cal Center has four adult Intensive Care Units (ICUs) with different
profiles: cardiology-hematology, surgery, and traumatology and two
ICUs with a pediatric profile (neonatal and pediatric ICU).
Culture results, corresponding to anaerobic blood culture bottles
from adult patients (≥18 years) were collected by an electronic search
of the Institutional laboratory information system (LIS) records for the
corresponding 5-year study period. The data collection included data
corresponding to samples from inpatient departments (i.e. hospitalized
patients) and the emergency department, while samples from outpa-
tient clinics was excluded from the analysis. Isolates were considered
separate if they occurred more than 14 days apart [14]. Time-to-pos-
itivity (TTP) data corresponding to the positive blood culture bot-
tles was also collected. Polymicrobial bacteremia was defined by the
isolation of more than one organism in a single blood culture [14].
In addition, patient data were also collected on patients who had at
least one positive blood culture yielding anaerobic bacteria or co-iso-
lation of multiple bacteria involving at least one anaerobic species.
The study was deemed exempt from ethics review by the Institutional
Review Board and informed consent was not required as patient's data
anonymity was maintained.
2.2. Sample processing and microbial identification
The processing of blood culture bottles was carried out in accor-
dance with national and international guidelines [15]. With the excep-
tion of the department of pediatrics, clinicians routinely used parallel
aerobic and anaerobic blood culture bottles in pairs, with most blood
cultures ordered as two sets, with one aerobic and one anaerobic bot-
tle per set. Blood cultures were analysed with a BacT/Alert 3D auto-
mated system (bioMérieux, Marcy l'Etoile, France) following inocu-
lation of 5–10mL of blood into aerobic and anaerobic bottles (BacT/
Alert FA and SN bottles; bioMérieux). Blood culture bottles were in-
cubated with constant shaking for 5 days and for 21 days, if endocardi-
tis was suspected, and monitored in accordance with the manufactur-
er's instructions.
Samples from positive anaerobic bottles were plated to the Colum-
bia agar base supplemented with 5% (v/v) sheep blood (bioMérieux,
Marcy l'Etoile, France), and chocolate PolyViteX agar (bioMérieux,
Marcy l'Etoile, France) for the cultivation of aerobic bacteria, eosin
methylene-blue agar (bioMérieux, Marcy l'Etoile,
France) for the selective growing of Enterobacterales was applied.
Samples from the positive bottles were also plated on Schaedler agar
(bioMérieux, Marcy l'Etoile, France) containing 5% v/v horse blood,
haemin and Vitamin K1. for the isolation of anaerobic bacteria; these
cultures were set up and incubated in an atmosphere of 90% N2, 5%
H2 and 5% CO2 in an anaerobic environment (Concept 400 anaerobic
incubator, Biotrace International Plc., UK) for 2–5 days at 37°C.
Identification of anaerobic isolates was carried out using matrix-as-
sisted laser desorption/ionization time-of-flight mass spectrometry
(MALDI-TOF MS), using the microFlex LT Biotyper (Bruker Dalton-
ics Gmbh., Bremen, Germany), the MALDI Biotyper RTC 3.1 soft-
ware (Bruker Daltonics, Germany) and the MALDI Biotyper Library
3.1 were used for spectrum analysis. Extraction steps with formic acid
were carried out before measurements to improve successful identi-
fication rates. Methodology of sample preparation and the technical
details of the mass spectrometry measurements were described pre-
viously [16]. Genus-level identification was considered reliable for
log(score)≥1.7, while this value for species level identification was
log(score)≥2.0.
Although Cutibacterium spp. isolates are not considered as
causative agents of bacteremia, these isolates were screened, based on
the criteria mentioned below to ascertain their possible clinical rele-
vance; isolates were considered clinically-relevant if a) endocarditis
was suspected, b) data on previous medical history was suggestive of
previous orthopedic surgery or implanted device, c) if Cutibacterium
spp. were detected from a pair of blood cultures simultaneously.
2.3. Statistical and comparative analysis
Statistical analyses, including descriptive analysis (means or me-
dians with ranges and percentages to characterize data) and statisti-
cal tests (Student's t-test and Mann-Whitney U test) were performed
with the SPSS software version 24 (IBM SPSS Statistics for Windows
24.0, IBM Corp., Armonk, NY, USA). The normality of variables was
tested using Shapiro–Wilk tests. p values < 0.05 were considered sta-
tistically significant.
The basis for the comparison is a study, which was carried out
in the same medical center over a similar time frame (5-years, be-
tween 2005 and 2009) [12]; the general and quantitative characteris-
tics, in addition to the instrumentation and identification methods used
in the two time periods (2005–2009 and 2013–2017) are summarized
in Table 1.
3. Results
Between 2013 and 2017, an average of 23,274± 2,756 blood cul-
ture bottles were received per year, out of which 10.5% presented
as culture-positive (including clinically-relevant isolates and conta-
minants). Overall, 3.3–3.6% of samples were positive for anaerobes
(or 0.4%, if all blood culture bottles are considered), representing
3.5–3.8 anaerobic isolates/1000 blood culture bottles (including both
aerobic and anaerobic bottles) per year. The number of hospitalized
patients did not change significantly between the two study periods
(p > 0.05), however, the number of blood culture bottles processed al-
most tripled. The relatively drastic decrease in the proportion of pos-
itive blood culture bottles (18.9% vs. 10.5%) should be attributed to
the significantly higher (p = 0.008) number of bottles received during
the second study period (Table 1). Similarly, it may seem that more
anaerobic isolates were detected between 2005 and 2009 (4.0–6.3% of
positive blood culture bottles contained anaerobes, 0.7% in the over-
all number of submitted blood cultures, representing 5.4–8.7 anaer-
obic isolates/1000 blood culture bottles [including both aerobic
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Table 1
Comparison of the two respective study periods regarding study population size and
methodology.
Study period 2005–2009 [12] 2013–2017
Hospital bed count 1200 (acute) + 200
(chronic)
1465 (acute) + 355
(chronic)
Affected population ∼ 600,000 patients ∼ 600,000 patients
Number of hospitalized
patients (average ± SD)
84,043± 570 84,438± 1866
Number of blood cultures
bottles processed during
the study period
43,992 116,371
Percentage of positive blood
culture bottles for aerobic
and anaerobic bacteria
overall
18.9± 2.2% 10.5± 0.3%
Percentage of positive blood
culture bottles for
anaerobes (compared to
the overall number of
submitted blood cultures)
0.7± 0.03% 0.4± 0.05%
Number of strict anaerobic
isolates
305 isolates 423 isolates
Number of strict anaerobic
isolates/1000
hospitalizations
0.7 1.0
Methods used ifor microbial
identification
Presumptive
identification methods
(Wadsworth Anaerobic
Bacteriology Manual),
Rapid ID 32A
(bioMérieux)
MALDI-TOF MS
(Bruker Daltonics),
extraction with
formic acid before
measurements
Blood culture detection
system
BD Bactec (Beckton
Dickinson)
BacT/Alert 3D
(bioMérieux)
Incubation time 5 days (if endocarditis is suspected: 21 days)
and anaerobic bottles] per year). However, the absolute number of
anaerobic isolates (n = 305 in 2005–2009 vs. n= 423 in 2013–2017;
p= 0.018) and the number of isolates corresponding to the number of
hospitalized patients (0.7/1000 hospitalizations in 2005–2009 vs. 1.0/
1000 hospitalizations in 2013–2017), reveal an increase in the number
of anaerobes isolated.
The epidemiological characteristics of affected patients and the in-
dications for blood culture submissions corresponding to blood cul-
tures positive for anaerobes are presented in Table 2. With regards to
the demographic characteristics of the affected patients, the mean age
in the present study period was around 70–73 years (range: 18–102
years) and a pronounced female dominance could be observed
(male-to-female ratio: 0.60). Compared to 2005–2009, the mean age
of patients increased considerably (mean: 60 years, range: 31–84
years) and the gender distribution has also shifted (male-to-female ra-
tio: 1.5). The most prevalent indications for blood culture submis-
sions in the present period were consistent with risk factors described
in the literature: cardiovascular diseases (19.9%), gastrointestinal dis-
eases (19.3%), hematological malignancies or solid tumors (8.0%),
respiratory diseases or pneumonia (6.4%), disorders of the urinary sys-
tem or hemodialysis (3.7%) and complications associated with dia-
betes (1.1%). Septicemia was reported in 21.6% of cases (Table 2), in
comparison, the number of affected patients on dialysis and reported
pneumonia was three times as high as in the previous study period;
similarly, sepsis was reported in only 15.9% of cases between 2005
and 2009. Most blood culture bottles positive for anaerobes (excluding
Cutibacterium spp.) originated from the intensive care units (44.5%),
followed by the department of internal medicine 24.6% (these depart-
ments were predominantly affected in the previous study period as
well [12]); the department of neurology (12.9%), psychiatry (9.9%),
surgery (3.6%), traumatology and rheumatology (1.3%, respectively),
urology (0.9%) and oncology/oncotherapy (0.8%) also sent in blood
culture bottles positive for anaerobic isolates.
The percentage distribution of isolated anaerobic species in the re-
spective time periods (2005–2009, 2013–2017) is presented in Table
3., while the detailed species distribution of isolates for both time pe-
riods is presented in Table 4. The majority of isolated anaerobes were
Cutibacterium (Propionibacterium) spp. (54.0± 8.5%; n= 247), sim-
ilarly to the previous study period (56.0 ± 8.4%; p> 0.05; Table 3.).
Out of the n= 247 isolates, none could be considered as clinically
significant, according to our criteria. Based on the species distribu-
tion of significant anaerobic bacteria in the respective study period,
no relevant shift could be observed among isolated species: (45.8%
vs. 38.9% for Gram-negatives, 54.2% vs. 61.1% for Gram-positives;
p> 0.05), although the ratio of Bacteroides/Parabacteroides isolates
increased compared to other Gram-negative anaerobes; members of
the Clostridium spp. were the second most common species in both
study periods (Tables 3 and 4). Between 2013 and 2017, the isolated
anaerobic strains belonged to 38 different anaerobic species, which
number is significantly higher (p= 0.028) than in the previous period
(n = 26). If the levels of identification are compared between the two
study periods, it can be observed that 92.2% of isolates were identi-
fied to the species level in the present study period. This ratio in the
Table 2
Epidemiological features of patient population and the indications for blood culture bottle submission (excluding those positive for C. acnes) between 2013 and 2017.
Study year 2013 2014 2015 2016 2017 Overall
Number of affected patients 27 28 34 41 57 187
Male-to-female ratio 1.5 0.3 0.4 0.5 0.4 0.6
Average age [year ± SD] 71.6± 13.5 70.9± 15.6 70.7± 17.8 73.0± 11.6 70.0± 17.1 71.9± 16.7
Age range [years] (42–94) (25–102) (19–94) (47–89) (18–96) (18–102)
Cardiovascular diseases 4 3 6 13 11 37
Respiratory diseases, pneumonia 2 0 1 3 6 12
Malignancy (solid or hematological) 4 1 0 4 6 15
Septicemia 3 10 7 8 12 40
Fever 5 1 3 5 5 19
Abdominal pain 8 9 6 0 9 32
Illness affecting the urinary system, hemodialysis 1 1 2 1 2 7
Osteomyelitis 0 2 0 0 0 2
Abscess 0 1 0 1 0 2
Illness affecting the gastro-intestinal system 0 0 4 5 4 13
Type II Diabetes 0 0 2 0 0 2
Neurological disease 0 0 1 1 1 3
Locomotor disease 0 0 2 0 1 3
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Table 3
Percentage distribution of anaerobes in the two respective study periods (2005–2009,
2013–2017).
Anaerobic isolates
aPercentage
of anaerobes
according to
literature
dataa
Results of the
previous
study
(2005–2009)
[12]
Results of
the present
study
(2013–2017)
Cutibacterium spp.b 30-80% (of
isolated
anaerobes)
56.0%
(n = 174)
54.0%
(n= 247)
All other isolates excluding Cutibacterium spp.
Gram-negative anaerobes 45.8%
(n=61)
38.9%
(n=69)
Bacteroides/Parabacteroides
spp.
26-75% 30.6%
(n = 41)
34.2%
(n= 54)
Fusobacterium spp. 4-15% 5.7% (n = 8) 1.2% (n = 2)
Prevotella and
Porphyromonas spp.
0.5-10% 5.7% (n = 8) 1.2% (n = 2)
Veillonella spp. 0.5-2% 3.7% (n = 4) 2.3% (n = 4)
Gram-positive anaerobes 54.2%
(n=73)
61.1%
(n=107)
Clostridium spp. 8-46% 30.6%
(n = 41)
33.3%
(n= 59)
Gram-positive anaerobic
cocci (GPAC)
8-20% 17.9%
(n = 24)
12.0%
(n= 21)
Gram-positive non-spore
forming rods (excluding:
Cutibacterium spp.)
0.5-14% 5.7% (n = 8) 15.8%
(n= 27)
a See References.
b Corresponding to all Cutibacterium spp. (btoh contaminants and clinically-relevant
isolates).
2005–2009 period was only 77.6% (p = 0.031). Polymicrobial anaero-
bic bacteremia is considered very rare, which is further highlighted by
our results: over the 5-year period (2013–2017), two anaerobes were
isolated simultaneously in five cases (Bacteroides spp. or Clostrid-
ium spp., together with a GPAC), while in 14 cases, one anaerobic
strain (Bacteroides spp. or Clostridium spp.) was co-isolated with a
facultative anaerobic bacteria (Escherichia coli, Klebsiella pneumo-
niae, Staphylococcus aureus, S. epidermidis).
The time-to-positivity (TTP) in blood cultures positive for anaer-
obes was 31.4± 23.4h for pathogens other than Cutibacterium spp.,
but much longer (112.9± 37.2h) for Cutibacterium spp. isolates,
(p < 0.0001).
4. Discussion
Despite their relatively low prevalence, anaerobic bacteria are im-
portant etiological factors in bloodstream infections and other inva-
sive infections. The knowledge of relevant risk factors is important to
maintain a degree of suspicion in clinicians and in selecting appro-
priate empirical antibiotic therapy. The local prevalence and species
distribution in this study is in line with the literature data (∼1.0/1000
hospitalized patients, 0.5–13% of positive blood cultures, most of-
ten Bacteroides/Parabacteroides spp. and Clostridium spp.), however,
due to the absence of other local data in Hungary, we were not able
to draw relevant national or institutional comparisons. Compared to
the previous five-year study period (2005–2009), the absolute number
of anaerobic isolates increased, both in respect to the number of in-
dividual isolates and in standardized values for hospitalized patients,
although this may seem proportionally lower, due to a significant in-
crease in the number of blood culture bottles submitted [12]. The
disproportionally high number of positive blood cultures originating
from the ICUs may be attributable to the logistical setup of the Clin-
ical Center (a larger, logistically more coherent single adult ICU has
been created in one place, instead of them being scattered). In the pre-
vious study, the 30-day crude mortality rate was determined (22.3%)
[12], however, in the present study, we did not have the opportunity to
observe the mortality rate, as the medical charts of the individual pa-
tients affected were not available during the survey.
Of particular interest is the appearance of various rare anaero-
bic species between 2013 and 2017, such as Actinotignum schaali,
Collinsella aerofaciens, Flavonifractor plautii, Solobacterium
moorei, and Tissierella praeacuta. Some of these microorganisms
have previously been designated into different genera (i.e. A. schaali
was formerly known as Actinobaculum schaalii, C. aerofaciens and F.
plautii were both designated in the Eubacterium genus, T. praeacuta
was previously Bacteroides praeacutus), while S. moorei (an identi-
fied contributor to halitosis) has only been known since the 2000s.
Their increasing detection rate is probably due to the growing num-
ber of laboratories nowadays which have the capabilities (polymerase
chain reaction, MALDI-TOF MS, 16S rRNA sequencing) that allow
for their accurate species level identification [17,18]. Additionally, an
increasing spectrum of organisms detected is also due to advances in
taxonomy, as many are being reclassified into different genera. In the
present study, all Cutibacterium spp. isolates were considered conta-
minants (based on our criteria described in the Results section), how-
ever, their clinical role is not to be dismissed as they are increasingly
being reported in the literature as potential pathogens [19]. C. acnes
is a member of the normal skin flora, and its role in the development
of acne vulgaris is well-known [20]; it is a very common contaminant
in blood cultures due to their anatomical location. Nevertheless, more
and more studies address its role in endocarditis, shunt infections, or-
thopedic infections (e.g., knee or hip replacement) and ocular infec-
tions and improved diagnostic methods may also aid in their potential
identification as pathogens [19].
A change in the blood culture detection systems (BD Bactec vs.
BacT/Alert 3D) occurred between the two respective study periods;
there is a large body of evidence demonstrating that automated sys-
tems using different detection methods for CO2 (colorimetric/fluo-
rescence measurement) have different efficacy in detecting anaero-
bic bacteria [21]. Fiori et al. demonstrated that BacT/Alert systems
showed a better recovery of Gram-positive microorganisms (both aer-
obes and strict anaerobes), while higher efficacy in the recovery of
Gram-negative bacteria was observed for the BACTEC system [22];
nonetheless, significant shifts towards either Gram-positive or
Gram-negative bacteria were not observed in our data, if the isola-
tion frequency of Gram-positive and Gram-negative microorganisms
are taken into consideration. In contrast, the study of Jeverica et al.
showed that BACTEC systems with lytic bottles were more effec-
tive and consistent in the detection of Cutibacterium spp. than BacT/
Alert systems [23]. In addition, some manufacturers' bottles may con-
tain components (such as sodium polyanethylene sulfonate or SPS)
that have been shown to inhibit the growth of certain anaerobic bac-
teria [24]. In our settings, blood culture bottles were changed in par-
allel with the detection systems; however the bottles used in the Insti-
tute reportedly do not contain such substances (based on manufactur-
er's specifications), therefore it is unlikely to have affected the isola-
tion rate and composition of strict anaerobes for this reason. Nonethe-
less, it should be pointed out that the different size, shape and han-
dling requirements of the different blood culture bottles for acquir-
ing samples aseptically, may have an effect on the ratio of contam-
inants (i.e. Cutibacterium spp.); however, relevant differences were
also not demonstrated (56.0% vs. 54.0% of overall isolates) in this re-
gard, between the two periods. Parallel to the change the blood culture
equipment, practical trainings were done time and again for appropri-
ate sampling methods for all of the clinical staff, especially the nurses,
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Table 4
Detailed characterization of anaerobic isolates from blood culture bottles (2005–2009 and 2013–2017).
Study year 2005–2009 2013 2014 2015 2016 2017 2013–2017
Number of anaerobic isolates 305 72 76 85 86 104 423
Microorganisms identified to the species level 26 14 12 15 13 26 38
Gram-positive, spore-forming anaerobic rods
Clostridium spp. (genus level) 13 0 1 0 0 0 1
C. butyricum 4 0 0 0 0 0 0
C. clostridioforme 0 1 0 0 0 0 1
C. perfringens 21 7 5 8 8 8 36
C. septicum 3 1 0 1 0 1 3
C. sordelii 0 1 0 1 0 1 3
C. tertium 0 1 0 0 0 0 1
C. paraputrificum 0 0 1 0 1 1 3
C. ramosum 0 0 2 0 1 1 4
C. innocuum 2 0 0 2 0 1 3
C. sporogenes 0 0 0 0 0 1 1
C. symbiosum 0 0 0 0 0 2 2
C. hathewayi 0 0 0 0 0 1 1
Gram-positive, non-spore-forming anaerobic rods
Actinotignum schaali 0 0 0 0 0 1 1
Actinomyces spp. (genus level) 1 0 0 0 0 0 0
A. odontolyticus 0 0 1 1 1 1 3
A. neuii 0 0 0 1 0 0 1
Bifidobacterium pseudocatenulatum 0 0 0 1 0 0 1
B. dentium 0 0 0 1 0 0 1
Cutibacterium (Propionibacterium) spp. (genus level) 1 1 8 4 1 5 19
C. acnes 171 42 40 52 50 41 225
C. avidum 0 1 0 1 0 0 2
C. granulosum 2 1 0 0 0 0 1
Collinsella aerofaciens 0 0 0 0 0 1 1
Eggerthella lenta 3 1 1 0 4 1 7
Eubacterium limosum 0 0 0 0 0 2 2
Flavonifractor plautii 0 0 0 0 1 0 1
Lactobacillus spp. (genus level) 12 2 3 2 1 1 9
Solobacterium moorei 0 0 0 0 1 1 2
Gram-positive anaerobic cocci (GPAC)
Anaerococcus spp. 0 0 0 0 0 1 1
Finegoldia magna 2 0 0 0 1 1 2
Parvimonas micra 10 0 1 1 3 6 11
Peptinophilus asaccharolyticus 9 0 0 0 0 0 0
P. harei 0 0 1 2 0 3 6
Peptostreptococcus spp. (genus level) 0 0 1 0 0 0 1
P. anaerobius 3 0 0 0 0 0 0
Gram-negative anaerobic rods
Bacteroides spp. (genus level) 8 0 1 0 0 0 1
B. fragilis 14 9 8 5 11 14 47
B. caccae 2 0 0 0 0 0 0
B. vulgatus 0 1 1 0 0 0 1
B. thetaiotaomicron 6 0 1 1 0 1 3
B. merdae 1 0 0 0 0 0 0
B. ovatus 0 0 0 0 0 1 1
B. pyogenes 1 0 0 0 0 1 1
Fusobacterium nucleatum 8 0 0 0 0 0 0
F. necrophorum 2 1 0 0 0 1 2
Prevotella buccae 3 0 0 0 0 0 0
P. denticola 2 1 0 0 0 0 1
P. melaninogenica 1 0 0 1 0 0 1
P. oralis 1 0 0 0 0 0 0
Tissierella praeacuta 0 0 0 0 0 1 1
Gram-negative anaerobic cocci
Veillonella atypica 0 1 0 0 1 1 3
V. dispar 0 0 0 0 1 0 1
V. parvula 3 0 0 0 0 0 0
ICU practitioners, residents and nursekeepers. This included the strict
adherence to Instuttional and international guidelines and sample or-
dering practices for blood culture bottles (i.e. to order two sets of one
aerobic and one anaerobic blood culture bottle per set), which was not
necessary the case in the previous study period [12].
We have also collected data on blood culture TTP, associated with
the isolation of anaerobes: in many cases, TTP may provide clinically
relevant information to the physicians, regarding the pathogen/conta-
minant status of the isolated species. Correlation between clinical out-
come of patients and TTP values has been reported previously [25].
Based on our present observations and in accordance with the lit-
erature, a “threshold” of approximately 60h of TTP may be estab-
lished, where the isolated anaerobic species is no longer expected to
be clinically significant, based on our criteria (taking into account the
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underlying illnesses of the patient), aiding physicians in the choice of
empiric antibiotic therapy. However, it is also important to note that
some Prevotella and Porphyromonas species may have TTP values up
to 80–100h (due to their slow generation times, especially if they are
represented in the sample with low colony forming unit count [26]),
which overlaps with the TTP values of Cutibacterium spp. In our set-
tings, this was not observed as a confounding factor (the TTP values
of Prevotella and Porphyromonas species were below 55h in every
case).
A number of different studies reported on the recovery of anaer-
obes in patients with bacteremia during the last several decades
[1,5–7]; however, at the same time, conflicting data has accumu-
lated regarding the incidence of anaerobic bacteremia. Earlier studies
showed that anaerobes account for around 20% of all cases bacteremia
[26], however, more recent data suggest that obligate anaerobic bac-
teria account for about 5% of bacteremia (range: 0.5%–13% of bac-
teremias; approximately 0.1% of hospital admissions) [1,4,6,7,10,12].
There may be multiple reasons explaining the different observations
in other studies regarding the epidemiology of anaerobic bacteremia
[27,28]: the re-emergence of anaerobic bacteremia may depend on an-
tibiotic policies of the hospital, the different geographical regions and
differences in the study population, including the patient age, immune
status, prevalence and severity of underlying diseases, social status
and other factors (such as malnutrition or on the contrary, obesity).
Older patients seem to be at increased risk for developing anaerobic
bacteremia, while children, especially between 2 and 5 years of age
have the lowest risk [29].
In the last decade, the decrease in the incidence of anaerobic bac-
teremia was reported in some publications [28,30–32]. In contrast to
these reports, other publications reported a considerable increase in
the incidence of anaerobic bacteremia. In the pivotal publication by
Cockerill et al., corresponding to the period between 1984 and 1992,
a considerable increase in the incidence of anaerobic bacteremia was
noted at the Mayo Clinic [33] and later, another retrospective study
report from the same institution also observed an increase in inci-
dence during the subsequent 12-year period (from 1993 through 2004)
[28]. In a 12-year study at an Australian general hospital, Riley and
Arvavena [34] found a 200% increase in the incidence of anaero-
bic bacteremia, with Fusobacterium spp. and Gram-positive anaero-
bic cocci (GPAC) being more frequently identified. Other investiga-
tors have also reported increases in the incidence of anaerobic bac-
teremia, particularly during the late 1990s and early 2000s [35–37].
Reasons for this increase were unclear: some authors hypothesized
that the routine use of inappropriate antibiotic prophylaxis and/or
bowel preparations prior to abdominal surgery may explain this phe-
nomenon. Because the decrease/increase in the incidence of anaero-
bic bacteremia varied from study to study, selective rather than rou-
tine use of an anaerobic bottle for culturing blood samples has been
proposed in the medical literature. According to the suggestions of
Badri et al. [14], is not necessary to detect anaerobic bacteremia in pa-
tients by microbiological methods, as the patients could be identified
clinically; and if it is likely that they will have anaerobic bacteremia
with a high degree of predictability, they should be treated empiri-
cally without the need for microbiological confirmation. The utility
of anaerobic blood cultures remains a controversial topic, while re-
ports suggesting that anaerobic sepsis, especially in patients with rel-
evant risk factors and severe underlying diseases is becoming more
prevalent. According to our point of view and our current clinical
observations, routine anaerobic blood cultures should not be aban-
doned. Additionally, the increasing resistance rates in anaerobes and
the presence of multidrug resistant isolates (most commonly in Bac
teroides/Parabacteroides spp.) are also important reasons for per-
forming anaerobic bacteriology in cases of possible or suspected
anaerobic bacteremia.
Only a small number of comparative studies can be found in the
literature on the incidence of anaerobic bacteremia in the same study
site over different periods of time. According to Dorsher et al., the
incidence of anaerobic bacteremia from 1974 to 1988at the Mayo
Clinic (Rochester, MN), decreased by 45.0% [31], in addition, the pos-
itive rate of blood cultures for anaerobes decreased significantly, even
though the total number of submitted blood cultures increased. The
number of anaerobic bacteremias per 100,000 patient-days also de-
clined over this 15-year period. Strains of the Bacteroides/Parabac-
teroides genus ranked third in frequency if compared to other or-
ganisms causing aerobic and anaerobic bacteremia in 1974, while
they were only the seventh most common bacteria in 1988, causing
slightly less than half of the anaerobic bacteremias. The mechanisms
responsible for these changes are unclear, but might relate to ear-
lier recognition and treatment of localized anaerobic infection, wide-
spread preoperative use of agents prior to bowel surgery, and use of
broad-spectrum antimicrobial regimens that included agents with ac-
tivity against anaerobes. A later study from the same hospital indi-
cated the re-emergence of anaerobic bacteremia in the 12-year period
from 1993 through 2004 [14]. Medical records for patients with anaer-
obic bloodstream infections were analysed throughout the study pe-
riod to identify differences between these two patient populations with
different rates of bacteremia. The number of anaerobic blood cultures
per 1000 cultures performed increased by 30%. The mean incidence
of anaerobic bacteremias increased from n= 53 cases per year dur-
ing 1993–1996, to n= 75 cases per year during 1997–2000, followed
by n= 91 cases per year during 2001–2004; the total number of cases
of anaerobic bacteremia per 100,000 patient-days increased by 74%.
They reported the following species-distribution from the positive
anaerobic blood cultures in the different time periods: Bacteroides/
Parabacteroides spp. were most commonly isolated (26.0–43.0%),
other anaerobic Gram-negative bacteria in 8–25%, Prevotella and
Porphyromonas spp. in 2%–10%, GPAC in 20–35%, Clostridium
spp.in 16%–46% and non-spore forming Gram-positive bacteria in
4%–18%, respectively (1993–2004). Their data showed a striking
revelation: 38% of patients with anaerobic bacteremia in 2004 had
sources other than the genito-urinary and/or gastrointestinal tracts and
by way of warning that in 34.3% of patients, anaerobes would have
not been suspected as the cause of bacteremia on the basis of “typi-
cal” clinical predictors. They concluded that sources of anaerobic bac-
teremia are now more varied than previously described, especially
among older and immunosuppressed patients and those patients who
suffered from complex underlying disease.
5. Conclusions
Anaerobic blood cultures may be helpful when anaerobic bac-
teremia is clinically suspected, i.e. in patients with advanced age and/
or in severely immunocompromised state, with serious underlying dis-
eases, in which case the correct source of bacteremia is not identified
by clinical evaluation. The prevalence of anaerobic bacteremia in rela-
tion to patient demographics should be determined on an institutional
basis to guide blood-culture practices. This approach is important to
provide timely and optimal treatment for patients. The use of mod-
ern diagnostic modalities (MALDI-TOF MS, PCR) in routine anaero-
bic diagnostics may aid in getting a better view into the frequency of
anaerobic bacteria isolated from blood.
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